Cargando…
Cross-Reactive and Lineage-Specific Single Domain Antibodies against Influenza B Hemagglutinin
Influenza B virus (IBV) circulates in the human population and causes considerable disease burden worldwide, each year. Current IBV vaccines can struggle to mount an effective cross-reactive immune response, as strains become mismatched, due to constant antigenic changes. Additional strategies which...
Autores principales: | Ramage, Walter, Gaiotto, Tiziano, Ball, Christina, Risley, Paul, Carnell, George W., Temperton, Nigel, Cheung, Chung Y., Engelhardt, Othmar G., Hufton, Simon E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640691/ https://www.ncbi.nlm.nih.gov/pubmed/31544820 http://dx.doi.org/10.3390/antib8010014 |
Ejemplares similares
-
Nanobodies mapped to cross-reactive and divergent epitopes on A(H7N9) influenza hemagglutinin using yeast display
por: Gaiotto, Tiziano, et al.
Publicado: (2021) -
The Breadth of Cross Sub-Type Neutralisation Activity of a Single Domain Antibody to Influenza Hemagglutinin Can Be Increased by Antibody Valency
por: Hufton, Simon E., et al.
Publicado: (2014) -
Development of an ELISA-Based Potency Assay for Inactivated Influenza Vaccines Using Cross-Reactive Nanobodies
por: Cheung, Chung Y., et al.
Publicado: (2022) -
Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity
por: Del Rosario, Joanne Marie M., et al.
Publicado: (2020) -
Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy
por: Tung Yep, Andrew, et al.
Publicado: (2021)